During this hour-long panel discussion at Pharma Integrates 2020, tranScrip's Managing Partner, Flic Gabbay, joined other health care professionals to explore what we are doing differently now that’s better than before and what we foresee might be future benefits of new ways of working.
- Tina Flatau, Chief Executive Officer, Biopharma Projects
- David Hawkins, Founder and Chief Executive Officer, Remedium Capital
- Flic Gabbay, Managing Partner, tranScrip
- Graham Wylie, Chief Executive Officer, MRN
- Helen Barker, Head of Pharmaceutical Development, Reneo Pharma
- Sean Breen, Head Public Private Partnerships and Science Policy, Takeda